⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NBP News
NovaBridge Biosciences American Depositary Shares
NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026
globenewswire.com
NBP
NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
NBP
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
globenewswire.com
NBP
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
globenewswire.com
NBP
NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei
globenewswire.com
NBP
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
prnewswire.com
GTBP
IBRX
ERAS
CHRS
NBP
NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer
globenewswire.com
NBP
NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026
globenewswire.com
NBP
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO
globenewswire.com
NBP
NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO
globenewswire.com
NBP